Antibiotics in Refractory IBD: Not Without Risks but Are the Alternatives Better? Response to Gilmore et al

被引：1

作者：

Turner, Dan ^{[1
]}

机构：

[1] Hebrew Univ Jerusalem, Shaare Zedek Med Ctr, Jerusalem, Israel

来源：

INFLAMMATORY BOWEL DISEASES | 2020年 / 26卷 / 05期

关键词：

D O I：

10.1093/ibd/izaa039

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：E42 / E42

页数：1

共 50 条

[41] Response to Harrison et al. 'Young men's HIV risks in South Africa:: the importance of multiple risk behaviors'
Lane, Tim
AIDS, 2006, 20 (10) : 1468 - 1469
[42] Clarifications on taking stock of legal trade in wildlife and potential risks to human health in response to Eskew et al., 2019
Can, Ozgun Emre
D'Cruze, Neil
Macdonald, David W.
GLOBAL ECOLOGY AND CONSERVATION, 2019, 20
[43] Response to "Response to Zhang et al.: Levetiracetam vs. brivaracetam for adults with refractory focal seizures: A meta-analysis and indirect comparison"
Zhang Lin
Zou Xiaoyi
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2016, 41 : 184 - 186
[44] Response to: Lagunes-Cordoba et al 'International medical graduates: how can UK psychiatry do better?' reply
Lagunes-Cordoba, Emmeline
BJPSYCH BULLETIN, 2022, 46 (02): : 130 - 130
[45] Response to Wang et al., "Paroxetine is an effective treatment for refractory erythema of rosacea: Primary results from the Prospective Rosacea Refractory Erythema Randomized Clinical Trial"
Sauer Jr, John
Zanghi, Nicholas
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 90 (04) : e145 - e146
[46] Response to Comment on "Organ Preservation for cT2N0 Distal Rectal Cancer-Are There Any Better Surgical Alternatives Without Chemoradiation?''
Habr-Gama, Angelita
Sao Juliao, Guilherme P.
Vailati, Bruna B.
Fernandez, Laura M.
Araujo, Sergio E. A.
Sabbaga, Jorge
Aguilar, Patricia B.
Perez, Rodrigo O.
ANNALS OF SURGERY, 2019, 270 (06) : E119 - E120
[47] Letter in response to Xiao et al: ED50 and ED95 of intrathecal bupivacaine with or without phenylephrine
Saikia, Priyam
Karim, Habib Md Reazaul
REGIONAL ANESTHESIA AND PAIN MEDICINE, 2020, 45 (03)
[48] High-dose cyclophosphamide therapy without stem cell rescue for severe refractory autoimmune illnesses: comment on the article by Moore et al
Prestrud, AA
Hoch, S
Brodsky, I
Gladstone, DE
ARTHRITIS AND RHEUMATISM, 2003, 48 (05): : 1463 - 1463
[49] Response to letter by Wang et al.: Comparing cardioprotection by remote ischaemic preconditioning in patients with and without diabetics In Reply
Kottenberg, E.
Peters, J.
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2014, 58 (06) : 769 - 769
[50] Response to “On the choice of methodology for evaluating dose-rate effects on radiation-related cancer risks” by Walsh et al.
Mark P. Little
David J. Pawel
Kossi Abalo
Michael Hauptmann
Radiation and Environmental Biophysics, 2021, 60 : 515 - 516

← 1 2 3 4 5 →